*Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Israel
†Université Paris Descartes, Sorbonne Paris Cité, APHP, Hôpital Necker Enfants Malades, Paris, France
‡The Hospital for Sick Children, University of Toronto, Canada
§Hospital Sant Joan de Déu, Barcelona, Spain
||Department of Paediatrics, University Hospital Motol, Prague, Czech Republic
¶Ist Department of Pediatrics, Semmelweis University, Budapest, Hungary
#Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, Italy
**Department of Woman, Child and General and Specialistic Surgery, University of Campania “Luigi Vanvitelli”, Napoli, Italy
††University Children's Hospital, Zurich, Switzerland
‡‡Schneider Children's Hospital, Petach Tikva, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Israel
§§Pediatric Department, University of Messina, Italy
||||National Children's Research Centre, Royal College of Surgeons of Ireland and University College Dublin, Ireland; and University College Dublin, Ireland
¶¶Southampton Children's Hospital, UK
##Helsinki University Children's Hospital, Department of Pediatric Surgery, Helsinki, Finland
***Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
†††Medical School and University Hospital of Ioannina, Greece
‡‡‡Barts and the London School of Medicine, Queen Mary University of London, UK
§§§Pediatric Gastroenterology and Nutrition Unit. Hospital Materno. IBIMA. Málaga, Spain
||||||||||Child Life and Health, University of Edinburgh, UK
¶¶¶BC Children's Hospital, University of British Columbia, Vancouver BC, Canada
###The Royal Hospital for Children, Glasgow, UK.
Address correspondence and reprint requests to Dan Turner, MD, PhD, Shaare Zedek Medical Center, Jerusalem, Israel (e-mail: email@example.com; firstname.lastname@example.org; email@example.com).
Received 16 December, 2017
Accepted 16 April, 2018
D.T., F.M.R., E.O.-M., A.M.G., J.M.de.C., J.B., G.V., M.A., C.S., C.P.B., A.A., C.R., S.H., M.S., M.P., L.de.R., K.H.K., N.C., V.M.N.-L., D.C.W., S.L. and R.K.R. contributed equally to this work.
Disclaimer: ESPGHAN is not responsible for the practices of physicians and provides guidelines and position papers as indicators of best practice only. Diagnosis and treatment is at the discretion of physicians.
Funding: European Crohn's and Colitis Organization (ECCO) and the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN).
Conflict of interests: DT- last 3 years received consultation fee, research grant, royalties, or honorarium from Janssen, Pfizer, Hospital for Sick Children (PUCAI royalties from industry trials), Ferring, AstraZeneca, Abbvie, Takeda, Ferring, Boehringer Ingelheim, Biogen, Atlantic Health, Shire, Celgene
JMdC-last 3 years received consultation fee, research grant, travel grant, or honorarium from Abbvie, Abbot, Nestle, MSD, Otsuka, Faes, Nutricia, Fresenius
JB received honoraria, speaker's fees and/or congress fees from AbbVie, MSD, Nestle, Nutricia and Biocodex.
GV- received consultation fee from Nestle, Danone and Abbvie.
MA last 3 years received honorarium from AbbVie
FMR received speaker fees from: Schering-Plough, Nestl,, Mead Johnson, Ferring, MSD, Johnson & Johnson, Centocor, AbbVie; serves as a board member for: SAC:DEVELOP (Johnson & Johnson), CAPE (ABBVIE), LEA (ABBVIE) and has been invited to MSD France, Nestl, Nutrition Institute, Nestl, Health Science, Danone, TAKEDA, CELGENE, BIOGEN, SHIRE, PFIZER, THERAKOS
AA- Received research grant from AbbVie
SH- received a travel bursary from AbbVie
LdR - last 3 years received consultation fee, research grant, or honorarium from ZonMw (national health institute), Janssen, Pfizer, Mundipharma, Shire and Abbvie
KK - Honoraria for consulting services (educational services, scientific articles, participation in Advisory Boards, clinical trials, other) from the companies as follows AbbVie, ENORASIS, Ferring, JANNSEN, MSD and Takeda
VNL last 3 years received consultation fee or honorarium from Abbvie, Otsuka and Nestl, Health Science
SL - last 2 years received honorarium from Janssen
RKR has received speaker's fees, travel support, or has performed consultancy work with Nestl, Health Science, AbbVie, Napp, Celltrion, Shire and Janssen.
MS, CS, CB, CR No conflict of interests to declare
EO has received honoraria from Abbvie.
NC research funding for trials, speaker fees and travel for conferences from Takeda, Shire, Celgene, Roche
MP lectures and congress fees sponsored by Astellas, Baxter and Shire.
AMG consultancy, speakers fees or research support for Abbvie, Celgene, Ferring, Gilead, Janssen, Pfizer and Takeda.
DCW has received speaker's fees, travel support, or has performed consultancy work with Abbvie, Takeda and Falk.
“ASC Tables of evidence 14.12.17”, Supplemental Digital Content, http://links.lww.com/MPG/B395.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.jpgn.org).